Literature DB >> 33422522

Discriminative SKP2 Interactions with CDK-Cyclin Complexes Support a Cyclin A-Specific Role in p27KIP1 Degradation.

Marco Salamina1, Bailey C Montefiore1, Mengxi Liu2, Daniel J Wood1, Richard Heath1, James R Ault3, Lan-Zhen Wang1, Svitlana Korolchuk1, Arnaud Baslé4, Martyna W Pastok1, Judith Reeks1, Natalie J Tatum1, Frank Sobott3, Stefan T Arold5, Michele Pagano2, Martin E M Noble1, Jane A Endicott6.   

Abstract

The SCFSKP2 ubiquitin ligase relieves G1 checkpoint control of CDK-cyclin complexes by promoting p27KIP1 degradation. We describe reconstitution of stable complexes containing SKP1-SKP2 and CDK1-cyclin B or CDK2-cyclin A/E, mediated by the CDK regulatory subunit CKS1. We further show that a direct interaction between a SKP2 N-terminal motif and cyclin A can stabilize SKP1-SKP2-CDK2-cyclin A complexes in the absence of CKS1. We identify the SKP2 binding site on cyclin A and demonstrate the site is not present in cyclin B or cyclin E. This site is distinct from but overlapping with features that mediate binding of p27KIP1 and other G1 cyclin regulators to cyclin A. We propose that the capacity of SKP2 to engage with CDK2-cyclin A by more than one structural mechanism provides a way to fine tune the degradation of p27KIP1 and distinguishes cyclin A from other G1 cyclins to ensure orderly cell cycle progression.
Copyright © 2021 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  cell cycle; checkpoint; protein kinase; signaling; ubiquitination

Mesh:

Substances:

Year:  2021        PMID: 33422522      PMCID: PMC7895821          DOI: 10.1016/j.jmb.2020.166795

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  60 in total

1.  Three different binding sites of Cks1 are required for p27-ubiquitin ligation.

Authors:  Danielle Sitry; Markus A Seeliger; Tun K Ko; Dvora Ganoth; Sadie E Breward; Laura S Itzhaki; Michele Pagano; Avram Hershko
Journal:  J Biol Chem       Date:  2002-07-24       Impact factor: 5.157

2.  Noncatalytic requirement for cyclin A-cdk2 in p27 turnover.

Authors:  Xin-Hua Zhu; Hoang Nguyen; H Dorota Halicka; Frank Traganos; Andrew Koff
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

3.  Protein Structure Modeling with MODELLER.

Authors:  Benjamin Webb; Andrej Sali
Journal:  Methods Mol Biol       Date:  2021

Review 4.  Deregulation of F-box proteins and its consequence on cancer development, progression and metastasis.

Authors:  Jinho Heo; Rebeka Eki; Tarek Abbas
Journal:  Semin Cancer Biol       Date:  2015-09-30       Impact factor: 15.707

5.  The structural basis for specificity of substrate and recruitment peptides for cyclin-dependent kinases.

Authors:  N R Brown; M E Noble; J A Endicott; L N Johnson
Journal:  Nat Cell Biol       Date:  1999-11       Impact factor: 28.824

6.  Regulation of cyclin A-Cdk2 by SCF component Skp1 and F-box protein Skp2.

Authors:  C H Yam; R W Ng; W Y Siu; A W Lau; R Y Poon
Journal:  Mol Cell Biol       Date:  1999-01       Impact factor: 4.272

7.  p27 binds cyclin-CDK complexes through a sequential mechanism involving binding-induced protein folding.

Authors:  Eilyn R Lacy; Igor Filippov; William S Lewis; Steve Otieno; Limin Xiao; Sonja Weiss; Ludger Hengst; Richard W Kriwacki
Journal:  Nat Struct Mol Biol       Date:  2004-03-14       Impact factor: 15.369

8.  DAMMIF, a program for rapid ab-initio shape determination in small-angle scattering.

Authors:  Daniel Franke; Dmitri I Svergun
Journal:  J Appl Crystallogr       Date:  2009-01-24       Impact factor: 3.304

9.  Differential Regulation of G1 CDK Complexes by the Hsp90-Cdc37 Chaperone System.

Authors:  Stephen T Hallett; Martyna W Pastok; R Marc L Morgan; Anita Wittner; Katie L I M Blundell; Ildiko Felletar; Stephen R Wedge; Chrisostomos Prodromou; Martin E M Noble; Laurence H Pearl; Jane A Endicott
Journal:  Cell Rep       Date:  2017-10-31       Impact factor: 9.423

Review 10.  The ubiquitin proteasome system - implications for cell cycle control and the targeted treatment of cancer.

Authors:  Florian Bassermann; Ruth Eichner; Michele Pagano
Journal:  Biochim Biophys Acta       Date:  2013-03-01
View more
  3 in total

1.  miR-590-5p Targets Skp2 to Inhibit the Growth and Invasion of Malignant Melanoma Cells.

Authors:  Yang Tong; Lei Jin
Journal:  Dis Markers       Date:  2022-07-07       Impact factor: 3.464

2.  Bipartite binding of the N terminus of Skp2 to cyclin A.

Authors:  Susan Kelso; Stephen Orlicky; Jonah Beenstock; Derek F Ceccarelli; Igor Kurinov; Gerald Gish; Frank Sicheri
Journal:  Structure       Date:  2021-05-13       Impact factor: 5.871

3.  The Clinical Significance and Potential Molecular Mechanism of Upregulated CDC28 Protein Kinase Regulatory Subunit 1B in Osteosarcoma.

Authors:  Chaohua Mo; Le Xie; Chang Chen; Jie Ma; Yingxin Huang; Yanxing Wu; Yuanyuan Xu; Huizhi Peng; Zengwei Chen; Rongjun Mao
Journal:  J Oncol       Date:  2021-12-10       Impact factor: 4.375

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.